Section 01Application
These terms apply to any person or organisation (the Client) engaging Verattia Ltd (Companies House 16396655), registered in England and Wales, for claim-risk review services.
Instructing Verattia to proceed constitutes agreement to these terms.
Section 02Services provided
Doctor-led, pre-publication editorial review of marketing copy and related assets against publicly available UK frameworks, including:
- The CAP Code
- The Human Medicines Regulations 2012
- MHRA guidance
- GPhC guidance
- The GB Nutrition and Health Claims Register
- ASA sector-specific guidance
- CMA online endorsement guidance
- The DMCC Act 2024
Each engagement is scoped per asset by written agreement (email sufficient) before work begins.
Section 03Important limitations
- Verattia outputs are advisory and editorial. They do not constitute legal, regulatory or medical advice.
- Verattia does not guarantee compliance with any regulator, advertising standard or platform policy.
- Verattia does not guarantee approval by the ASA, MHRA, GPhC, CAP, any other regulator, or any advertising platform.
- Verattia does not provide legal representation or regulatory filings on the Client's behalf.
- Nothing in a Verattia output implies endorsement, approval or certification by any regulator or statutory body, including ASA, MHRA, GPhC, CAP, CQC, GMC or ICO.
- The Client remains solely responsible for obtaining independent legal and regulatory sign-off before publishing any reviewed asset.
Section 04Scope and instructions
Each engagement is defined in writing (email sufficient) and specifies: assets, applicable frameworks, deliverable and fee.
No new engagements are accepted on verbal instructions.
Section 05Fees and payment
Fees are agreed per engagement before work begins. Default terms: 50% on instruction, 50% on delivery. Fees are exclusive of VAT where applicable.
Late payment may pause work in progress.
Section 06Confidentiality
All Client materials, URLs, copy and commercial information are treated as confidential. We will not share or publish Client-identifiable information without express written consent.
Verattia may reference engagement type generically (without identifying the Client) for portfolio purposes, unless the Client opts out in writing.
Section 07Intellectual property and attribution
On full payment, the Client owns the engagement deliverable.
Verattia retains rights to its methodology, frameworks, risk-grading system and wording-bank structure for use in other engagements.
The Client may not publish, quote, paraphrase or otherwise attribute the names Dr Borna Farzaneh or Verattia on any public-facing asset, marketing material, regulator submission, press statement or third-party platform without Verattia's prior written consent. Internal use and confidential disclosure to the Client's professional advisers is permitted.
Section 08Limitation of liability
Verattia's total liability for any engagement is capped at the fee paid for that engagement.
Verattia accepts no liability for indirect, consequential or economic loss, including loss of profit, revenue, reputation or business opportunity.
Nothing in these terms limits liability for fraud or for death or personal injury caused by negligence.
Section 09Governing law
These terms are governed by the laws of England and Wales, with exclusive jurisdiction of the courts of England and Wales.
Section 10Changes
The version of these terms in force at the time of instruction applies to that engagement. The current version is published at www.verattia.com/terms.
Section 11Contact
Verattia Ltd · hello@verattia.com · Companies House 16396655.